Scopus İndeksli Yayınlar Koleksiyonu by Institution Author "Tezcan Karasu, Gulsun"
Now showing items 1-4 of 4
-
Genomic spectrum and phenotypic heterogeneity of human IL-21 receptor deficiency
Cagdas, Deniz; Baris, Safa; Worley, Lisa; Langley, David B.; Metin, Ayse; Karasu, Gulsun (Springer, 2021)Biallelic inactivating mutations in IL21R causes a combined immunodeficiency that is often complicated by cryptosporidium infections. While eight IL-21R-deficient patients have been reported previously, the natural course, ... -
Hematopoietic stem cell transplantation in CD40 ligand deficiency: a single-center experience
Uygun, Dilara Fatma Kocacik; Uygun, Vedat; Tezcan Karasu, Gulsun; Daloglu, Hayriye; Ozturkmen, Seda Irmak; Celmeli, Fatih; Torun, Selda Hancerli; Ozen, Ahmet; Baris, Safa; Aydiner, Elif Karakoc; Yalcin, Koray; Kilic, Suar Caki; Hazar, Volkan; Bingol, Aysen; Yesilipek, Akif (Wiley, 2020)Deficiency of the CD40L, expressed on the surface of T lymphocytes, is caused by mutations in the glycoproteinCD40L (CD154)gene. Resulting defective humoral and cellular responses cause a clinical presentation that includes ... -
Ruxolitinib salvage therapy is effective for steroid-refractory graft-versus-host disease in children: a single-center experience
Uygun, Vedat; Tezcan Karasu, Gulsun; Daloglu, Hayriye; Ozturkmen, Seda; Kilic, Suar Caki; Yalcin, Koray; Celen, Safiye Suna; Hazar, Volkan; Yesilipek, Akif (Wiley, 2020)Background Despite the increasing performance of allogeneic hematopoietic cell transplantation over the last decades, graft-versus-host disease (GVHD) remains the main cause of morbidity and mortality. The efficacy of ... -
Use of low cell dose for unmanipulated donor lymphocyte for management of cytomegalovirus infection: a single-center experience
Uygun, Vedat; Tezcan Karasu, Gulsun; Daloglu, Hayriye; Ozturkmen, Seda; Yalcın, Koray; Celen, Safiye Suna; Yesilipek, Akif (2020)Although advancements have been made in monitoring and preventing viral infections in HSCT patients, CMV reactivation still remains a critical post-transplant complication. Adoptive cell therapy is an alternative to ...
